News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
419,616 Results
Type
Article (47624)
Company Profile (80)
Press Release (371912)
Section
Business (120730)
Career Advice (1303)
Deals (17806)
Drug Delivery (42)
Drug Development (51709)
Employer Resources (91)
FDA (8405)
Job Trends (8948)
News (199352)
Policy (15999)
Tag
Academia (2598)
Alliances (35828)
Alzheimer's disease (1107)
Approvals (8449)
Artificial intelligence (142)
Bankruptcy (91)
Best Places to Work (7022)
Breast cancer (155)
Cancer (1273)
Career advice (1084)
CAR-T (90)
Cell therapy (243)
Clinical research (40371)
Collaboration (529)
COVID-19 (1884)
C-suite (93)
Data (1232)
Diabetes (118)
Diagnostics (3894)
Drug discovery (78)
Earnings (43991)
Employer resources (80)
Events (51037)
Executive appointments (361)
FDA (8980)
Funding (406)
Gene therapy (167)
GLP-1 (381)
Government (2290)
Healthcare (10982)
Infectious disease (1953)
Inflammatory bowel disease (88)
Interviews (261)
IPO (8101)
Job creations (2240)
Job search strategy (941)
Layoffs (231)
Legal (3050)
Lung cancer (188)
Lymphoma (83)
Manufacturing (147)
Medical device (6266)
Medtech (6268)
Mergers & acquisitions (9983)
Metabolic disorders (296)
Neuroscience (1401)
NextGen: Class of 2025 (3355)
Non-profit (3574)
Northern California (1240)
Obesity (136)
Opinion (130)
Parkinson's disease (87)
Patents (92)
People (34127)
Phase I (12560)
Phase II (17263)
Phase III (13614)
Pipeline (608)
Postmarket research (1907)
Preclinical (6797)
Radiopharmaceuticals (164)
Rare diseases (191)
Real estate (3921)
Regulatory (11706)
Research institute (2499)
Resumes & cover letters (186)
Southern California (1082)
Startups (2295)
United States (11016)
Vaccines (424)
Date
Today (86)
Last 7 days (505)
Last 30 days (1657)
Last 365 days (21202)
2025 (3194)
2024 (21537)
2023 (24946)
2022 (34617)
2021 (36286)
2020 (33476)
2019 (27432)
2018 (20649)
2017 (20146)
2016 (20026)
2015 (24072)
2014 (18350)
2013 (16271)
2012 (16216)
2011 (16894)
2010 (15730)
Location
Africa (575)
Asia (34519)
Australia (5756)
California (2769)
Canada (1106)
China (285)
Colorado (113)
Connecticut (143)
Europe (62477)
Florida (436)
Georgia (97)
Illinois (244)
Indiana (163)
Japan (110)
Maryland (442)
Massachusetts (2065)
Michigan (124)
Minnesota (156)
New Jersey (952)
New York (951)
North Carolina (554)
Northern California (1240)
Ohio (105)
Pennsylvania (582)
South America (644)
Southern California (1082)
Texas (420)
Utah (80)
Virginia (83)
Washington State (322)
419,616 Results for "alcon research ltd".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
IPO
‘Valentine’s Day Massacre’: Deerfield Claims Alcon is Blocking Aurion’s IPO
Deerfield Management claims that Alcon Research is seeking a discounted takeover of Aurion Biotech while blocking the startup’s efforts to go public.
February 25, 2025
·
2 min read
·
Tristan Manalac
Policy
Sight Sciences Announces Successful $34 Million Patent Infringement Verdict Against Alcon and its Hydrus Microstent for Microinvasive Glaucoma Surgery
Sight Sciences, Inc. today announced that it received a positive jury trial verdict of $34 million associated with the patent infringement case it filed on September 16, 2021 against Alcon Inc., Alcon Vision, LLC, Alcon Research, LLC, and Ivantis, Inc.
April 29, 2024
·
6 min read
Policy
Alcon’s Latest Equipment Breakthrough Technologies, Unity VCS and Unity CS, Receive U.S. FDA 510(k) Clearance
Alcon, the global leader in eye care dedicated to helping people see brilliantly, announced that UNITY® Vitreoretinal Cataract System and UNITY® Cataract System have received U.S. Food and Drug Administration 510 clearance.
June 24, 2024
·
6 min read
Press Releases
Alcon Announces U.S. Launch of Voyager DSLT, First-of-its-Kind Treatment for Glaucoma and Ocular Hypertension
February 19, 2025
·
7 min read
Press Releases
Alcon to Present at 2025 Annual J.P. Morgan Healthcare Conference
January 2, 2025
·
1 min read
Press Releases
Alcon Announces U.S. Launch of New SYSTANE PRO Preservative-Free, Revolutionizing Dry Eye Relief With Its Longest Lasting Formula Yet
February 24, 2025
·
3 min read
Press Releases
WORK Medical Technology Group LTD Announces Strategic Partnership with Shanghai Chartwell Medical Device Co., Ltd.
March 3, 2025
·
5 min read
SEKISUI CHEMICAL CO., LTD. and RevolKa Signed a Contract Research Agreement
RevolKa Ltd., a venture-backed biotech company providing a game-changing protein engineering technology platform signed a contract research agreement with SEKISUI CHEMICAL CO., LTD..
January 23, 2024
·
2 min read
Press Releases
Boston Scientific announces agreement to acquire SoniVie Ltd.
March 4, 2025
·
7 min read
Business
Alcon Reports Third Quarter 2023 Results
Alcon, the global leader in eye care, reported its financial results for the three and nine months ended September 30, 2023.
November 14, 2023
·
29 min read
1 of 41,962
Next
